Kratom Reprieve From Scheduling Requested By House Members
This article was originally published in The Rose Sheet
Executive Summary
Members headed by Reps. Mark Pocan, D-WI, and Matt Salmon, R-AZ, say the proposal was made without allowing opportunity for comment by experts, supplement industry stakeholders and consumers.
You may also be interested in...
FDA Turns Kratom's Future In US Dietary Supplement Market Into History
FDA Commissioner Scott Gottlieb says kratom's apparently increasing use "as an alternative or adjunct to opioid use" has made enforcement on the ingredient more of a priority for FDA, and "given the scope of this crisis, we must do more."
Kratom Group Wants DEA Records: Health And Wellness Industry News
CRN pans AASLD study linking supplements to rash of liver injuries; ABC goes digital with "Identification of Medicinal Plants"; and AKA says DEA running "shadow campaign" to schedule kratom.
Controversy Brews With 'Inaccurate' Reports Linking Kratom To Deaths
American Kratom Association and independent researchers explain the ingredient's history of safe use in a media briefing. Medical examiners "have tried to pin on kratom" the recent deaths of men in Florida and New York, says trade group Chairman Dave Herman.